令和2年の東京都保菌者検索事業実施結果が確定いたしましたので、下記の通りお知らせします。
食品監視課食中毒調査担当
1 腸管出血性大腸菌の発生状況累計グラフ
(1)散発患者発生動向調査
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
O157VT2 |
2 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
2 |
2 |
O157VT1,2 |
1 |
0 |
0 |
1 |
4 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
4 |
2 |
その他 |
1 |
0 |
0 |
1 |
1 |
1 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
3 |
2 |
1 |
累計 |
4 |
5 |
5 |
7 |
13 |
14 |
16 |
16 |
17 |
18 |
18 |
18 |
18 |
18 |
20 |
25 |
33 |
38 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
O157VT2 |
5 |
6 |
0 |
1 |
1 |
1 |
5 |
2 |
3 |
4 |
3 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
O157VT1,2 |
3 |
3 |
3 |
3 |
10 |
17 |
11 |
16 |
11 |
3 |
0 |
1 |
2 |
1 |
3 |
1 |
2 |
0 |
その他 |
3 |
2 |
2 |
2 |
3 |
2 |
2 |
0 |
2 |
1 |
1 |
0 |
0 |
1 |
1 |
0 |
0 |
1 |
累計 |
49 |
60 |
65 |
71 |
85 |
105 |
123 |
141 |
157 |
165 |
169 |
171 |
174 |
176 |
180 |
181 |
183 |
184 |
(2)無症状病原体保有者調査
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
O157VT2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
O157VT1,2 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
その他 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
1 |
1 |
0 |
4 |
0 |
2 |
累計 |
1 |
1 |
1 |
1 |
2 |
2 |
2 |
2 |
3 |
4 |
4 |
5 |
6 |
7 |
7 |
11 |
11 |
14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
O157VT1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
O157VT2 |
2 |
4 |
2 |
0 |
0 |
0 |
2 |
4 |
2 |
0 |
1 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
O157VT1,2 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
3 |
1 |
0 |
1 |
1 |
0 |
0 |
0 |
0 |
その他 |
8 |
4 |
0 |
3 |
3 |
2 |
2 |
2 |
1 |
3 |
2 |
1 |
2 |
1 |
0 |
3 |
1 |
1 |
累計 |
25 |
33 |
35 |
38 |
41 |
43 |
48 |
55 |
58 |
64 |
69 |
70 |
73 |
75 |
75 |
80 |
81 |
82 |
2 サルモネラの発生状況累計グラフ
(1)散発患者発生動向調査
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
O4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
O7 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
O9 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
その他 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
累計 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
O4 |
0 |
0 |
0 |
1 |
0 |
1 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
O7 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
O9 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
その他 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
累計 |
0 |
0 |
1 |
2 |
2 |
3 |
5 |
6 |
7 |
7 |
7 |
7 |
7 |
8 |
8 |
9 |
9 |
9 |
(2)無症状病原体保有者調査
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
O4 |
1 |
1 |
0 |
1 |
0 |
0 |
4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
1 |
1 |
O7 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
2 |
1 |
O9 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
その他 |
2 |
0 |
0 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
累計 |
3 |
5 |
5 |
7 |
7 |
7 |
12 |
12 |
12 |
12 |
12 |
12 |
12 |
13 |
13 |
15 |
18 |
20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
O4 |
2 |
0 |
3 |
1 |
0 |
1 |
1 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
O7 |
2 |
0 |
2 |
1 |
0 |
1 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
O9 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
その他 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
累計 |
25 |
25 |
31 |
33 |
33 |
35 |
37 |
38 |
40 |
40 |
41 |
41 |
41 |
41 |
41 |
41 |
42 |
42 |
|